Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) Starts Presentation at 9th Annual LD Micro Invitational
Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use. For more information, visit the company's website at www.canntab.ca. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective…







